Evidence map›Paper›PMID 40242320›Full record

ArticleLancet regional health. Americas2025

Risk factors for Alzheimer's disease and cognitive function before middle age in a U.S. representative population-based study.

Allison E Aiello, Jennifer Momkus, Rebecca C Stebbins, Yuan S Zhang, Chantel L Martin, Y Claire Yang, Lauren Gaydosh, Taylor Hargrove, Adina Zeki Al Hazzouri, Kathleen Mullan Harris

Abstract read
In one paragraph

Article in Lancet regional health. Americas, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. The physiological effects of APOE genotype in healthy young/middle-aged individuals.Biological reviews of the Cambridge Philosophical Society · 2026
    Article
  5. APOE and plasma AD biomarkers: The role of genetic ancestry in Hispanics/Latinos.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2026
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Allison E AielloRobert N. Butler Columbia Aging Center, Columbia University, New York, NY, USA.
Jennifer MomkusCarolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Rebecca C StebbinsRobert N. Butler Columbia Aging Center, Columbia University, New York, NY, USA.
Yuan S ZhangRobert N. Butler Columbia Aging Center, Columbia University, New York, NY, USA.
Chantel L MartinCarolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Y Claire YangCarolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Lauren GaydoshCarolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Taylor HargroveCarolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Adina Zeki Al HazzouriRobert N. Butler Columbia Aging Center, Columbia University, New York, NY, USA.
Kathleen Mullan HarrisCarolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Funding

Wave IV Data CollectionP01HD031921 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HARRIS, KATHLEEN MULLAN · 1994 to 2020
$86.1M
National Longitudinal Study of Adolescent to Adult Health (Add Health): Wave VII Core ProjectU01AG071448 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Allison E Aiello, Lauren M Gaydosh · 2021 to 2026
$40.2M
National Longitudinal Study of Adolescent to Adult Health (Add Health): Wave VI Cognition and Early Risk Factors for Dementia ProjectU01AG071450 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI AIELLO, ALLISON E, HUMMER, ROBERT A · 2021 to 2025
$16.2M
Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
From Biological to Social Processes: Interdisciplinary Training in Life Course ResearchT32HD091058 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROBERT A HUMMER, Amanda L Thompson · 2017 to 2026
$4.3M
Program Development (Pilot) CoreP30AG066615 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ELIZABETH A FRANKENBERG · 2020 to 2026
$4.1M
Life Course Process of Alzheimer's Disease: Sex Difference and Biosocial MechanismsR01AG057800 · NIA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI YANG, YANG CLAIRE · 2017 to 2021
$3.6M
NIA NIH HHS P30 AG066615NIA NIH HHS R01 AG057800NIA NIH HHS U01 AG071448NIA NIH HHS U01 AG071450NICHD NIH HHS P01 HD031921NICHD NIH HHS P2C HD050924NICHD NIH HHS T32 HD091058
6 · The paper itself

Abstract

Background: Alzheimer's disease is a major health concern in the U.S., but most research has focused on older populations. We examined whether established risk factors and blood biomarkers are associated with cognition before midlife. Methods: Data from the National Longitudinal Study of Adolescent to Adult Health (Add Health) were analyzed. Participants were enrolled in 1994-95 (grades 7-12) and followed through 2018. We cross-sectionally analyzed weighted survey and biomarker data from Waves IV and V. We measured the Cardiovascular Risk Factors, Aging, and Incidence of Dementia (CAIDE) score comprised of age, education, sex, systolic blood pressure, body mass index, cholesteroal, and physical activity and apolipoprotein E ε4 allele (APOE ε4) status. We also measured total Tau and Neurofilament light (NfL), high sensitivity C-reactive protein (hsCRP), Interleukin (IL)-1β, IL-6, IL-8, IL-10, and Tumor necrosis factor alpha (TNF-α). Outcomes included immediate word recall, delayed word recall, and backward digit span. Findings: Analytic sample sizes ranged from 4507 to 11,449 participants in Wave IV and from 529 to 1121 participants in Wave V. The survey-weighted median (IQR) age was 28 (26-29) years in Wave IV and 38 (36-29) years in Wave V. About half of the survey-weighted Wave IV participants were female (48.4-52.1% across analytic samples), 71.4-72.5% were White, 12.5-14.9% were Black, and 9.3-10.2% were Hispanic. In Wave V, 43.6-46.8% were female, 68.7-69.3% were White, 17.1%-20.0% were Black, and 7.3%-9.6% were Hispanic. The CAIDE score was associated with all cognition measures in Wave IV. For example, among adults aged 24-34, each 1-point increase in CAIDE was associated with a 0.03 standard deviation lower backward digit span score (95% CI: -0.04, -0.02). Total Tau was associated with immediate word recall in Wave V (β = -0.13, 95% CI: -0.23, -0.04). Wave IV hsCRP and IL-10 and Wave V IL-6, IL-1β, and IL-8 were also associated with lower cognitive scores. Interpretation: Key risk factors for Alzheimer's Disease are linked to cognitive function as early as ages 24-44, highlighting the need for early prevention in the US. Funding: NIHP01HD31921, U01AG071448, U01AG071450, R01AG057800, P30AG066615, T32HD091058, P2CHD050924.

Indexed as

Alzheimer’s diseaseAPOEATN biomarkersCAIDE risk scoreCognitive functionDementia risk factorsDementia risk scoreEarly midlifeImmune biomarkersInflammatory biomarkersLife courseNeurofilament light chainPopulation-basedTauUS-RepresentativeYoung adulthood

Identifiers

PMID40242320
PMCPMC12001091

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.